These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15339692)

  • 1. Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes.
    Ashenden MJ; Sharpe K; Schoch C; Schumacher YO
    Haematologica; 2004 Aug; 89(8):1019-20. PubMed ID: 15339692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of reference ranges in elite athletes for markers of altered erythropoiesis.
    Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Ashenden MJ; Gore CJ; Parisotto R; Hahn AG
    Haematologica; 2002 Dec; 87(12):1248-57. PubMed ID: 12495898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of common hematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes.
    Parisotto R; Ashenden MJ; Gore CJ; Sharpe K; Hopkins W; Hahn AG
    Haematologica; 2003 Aug; 88(8):931-40. PubMed ID: 12935982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation blood tests to detect erythropoietin abuse by athletes.
    Gore CJ; Parisotto R; Ashenden MJ; Stray-Gundersen J; Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Hahn AG
    Haematologica; 2003 Mar; 88(3):333-44. PubMed ID: 12651273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.
    Ashenden MJ; Gore CJ; Parisotto R; Sharpe K; Hopkins WG; Hahn AG
    Haematologica; 2003 Sep; 88(9):1053-62. PubMed ID: 12969814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematocrit in elite athletes.
    Vergouwen PC; Collée T; Marx JJ
    Int J Sports Med; 1999 Nov; 20(8):538-41. PubMed ID: 10606218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengths and weaknesses of established indirect models to detect recombinant human erythropoietin abuse on blood samples collected 48-hr post administration.
    Connes P; Caillaud C; Simar D; Villard S; Sicart MT; Audran M
    Haematologica; 2004 Jul; 89(7):891-2. PubMed ID: 15257956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis.
    Parisotto R; Wu M; Ashenden MJ; Emslie KR; Gore CJ; Howe C; Kazlauskas R; Sharpe K; Trout GJ; Xie M
    Haematologica; 2001 Feb; 86(2):128-37. PubMed ID: 11224480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
    Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
    Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A third generation approach to detect erythropoietin abuse in athletes.
    Sharpe K; Ashenden MJ; Schumacher YO
    Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes.
    Parisotto R; Gore CJ; Hahn AG; Ashenden MJ; Olds TS; Martin DT; Pyne DB; Gawthorn K; Brugnara C
    Int J Sports Med; 2000 Oct; 21(7):471-9. PubMed ID: 11071048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of microdose recombinant human erythropoietin regimens in athletes.
    Ashenden M; Varlet-Marie E; Lasne F; Audran M
    Haematologica; 2006 Aug; 91(8):1143-4. PubMed ID: 16870547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-week traditional altitude training increases hemoglobin mass and red cell volume in elite biathlon athletes.
    Heinicke K; Heinicke I; Schmidt W; Wolfarth B
    Int J Sports Med; 2005 Jun; 26(5):350-5. PubMed ID: 15895317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.
    Wang G; Durussel J; Shurlock J; Mooses M; Fuku N; Bruinvels G; Pedlar C; Burden R; Murray A; Yee B; Keenan A; McClure JD; Sottas PE; Pitsiladis YP
    BMC Genomics; 2017 Nov; 18(Suppl 8):817. PubMed ID: 29143667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin and other blood-boosting methods.
    Pommering TL
    Pediatr Clin North Am; 2007 Aug; 54(4):691-9, x. PubMed ID: 17723871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin and packed-cell volume in endurance athletes prior to rhEPO.
    Kujala UM; Peltonen JE; Elovainio RO
    Int J Sports Med; 2000 Apr; 21(3):228-30. PubMed ID: 10834359
    [No Abstract]   [Full Text] [Related]  

  • 18. Rogue athletes and recombinant DNA technology: challenges for doping control.
    Azzazy HM; Mansour MM
    Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the physiological response to simulated altitude exposure and r-HuEpo administration.
    Ashenden MJ; Hahn AG; Martin DT; Logan P; Parisotto R; Gore CJ
    J Sports Sci; 2001 Nov; 19(11):831-7. PubMed ID: 11695504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total hemoglobin mass--a new parameter to detect blood doping?
    Prommer N; Sottas PE; Schoch C; Schumacher YO; Schmidt W
    Med Sci Sports Exerc; 2008 Dec; 40(12):2112-8. PubMed ID: 18981937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.